| Discussion information box |
|---|
The introduction to this discussion lists a number of questions related to preferences for term styles and hierarchy content. The file associated with this discussion is the notes view of slide #4 from a presentation given during the May 2019 OIDM meeting. There are three major questions I've associated with this slide and I'd like your help determining the answers.
- Should the drug names in these terms conform to names in the substance hierarchy?
- Should the "main" term, some combination of the drug name and either resistant or susceptible be hyphenated (e.g. "Cephalosporin-resistant") or not (e.g. Ampicillin resistant)?
- Should existing concepts involving specific antimicrobials (e.g. penicillin) be subtypes of concepts involving their nominal antimicrobial class (e.g. beta-lactam)?
There are a few follow up questions in the file.